Cumberland Pharmaceuticals CPIX Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's non-controlling interests?
- Cumberland Pharmaceuticals (CPIX) reported non-controlling interests of -$333.51K in Q1 2026.
- How has Cumberland Pharmaceuticals's non-controlling interests changed year-over-year?
- Cumberland Pharmaceuticals's non-controlling interests decreased by 5.4% year-over-year, from -$316.4K to -$333.51K.
- What is the long-term trend for Cumberland Pharmaceuticals's non-controlling interests?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's non-controlling interests has grown at a 23.5% compound annual growth rate (CAGR), from -$117.12K to -$336.1K.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.